Lakefront Biotherapeutics N.V.
LKFT | NASDAQ
$32.00
-$0.28 (-0.87%)
Nov 2, 2026, 11:59 AM ET · Market open
Market Data
Market Cap $2.1B
Enterprise Value $-381.55M
Beta 0.12
Average Volume 249.79K
Shares Outstanding (Diluted) 66.93M
Shares Change YoY 1.56%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US36315X1019
Price Performance
Price Change 1M 8.9%
Price Change 3M 19.7%
Price Change 6M 12.4%
Price Change YTD -2.1%
Price Change 1Y 3.3%
Price Change 3Y -13.7%
Price Change 5Y -43.2%
1M CAGR (ann.) 13.1%
1Y CAGR (ann.) 4.4%
5Y CAGR (ann.) -8.7%
All-Time CAGR -5.8%
Valuation
PE Ratio 3.06
Forward PE N/A
PEG Ratio -0.10
Forward PEG -0.07
PS Ratio 1.83
Forward PS 47.70
PB Ratio 0.57
P/FCF Ratio -9.18
P/Adj. FCF Ratio -9.18
P/OCF Ratio -6.23
EV/Sales -0.39
EV/EBIT -0.72
EV/EBITDA -0.70
EV/FCF 1.93
Earnings Yield 31.5%
FCF Yield -10.5%
Adj. FCF Yield -10.5%
Financial Health
Net Cash €2.24B
Total Debt €6.36M
Cash & Short-Term Investments €2.24B
Total Assets €3.35B
Current Ratio 30.48
Quick Ratio 30.30
Debt / Equity Ratio 0.00
Debt / EBITDA 0.01
Debt / FCF -0.03
OCF / Debt -30.32
Interest Coverage 171.26
Altman Z-Score 14.67
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 98.0%
Operating Profit Margin 61.6%
EBITDA Margin 33.3%
Net Profit Margin 46.8%
FCF Margin -19.9%
Adj. FCF Margin -19.9%
SBC / Revenue -1.2%
SBC Impact (per share) N/A
Returns
Return on Assets 14.5%
Return on Equity 16.9%
Return on Invested Capital 11.6%
Return on Capital Employed 11.6%
Return on Tangible Assets 14.5%
Historical Growth (CAGR)
Revenue CAGR 3Y 42.1%
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y 296.4%
EPS CAGR 5Y N/A
EPS CAGR 10Y N/A
FCF CAGR 3Y N/A
FCF CAGR 5Y N/A
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 2
EPS Growth Next 3Y -44.6%
Revenue Growth Next 3Y -66.4%
Earnings Date Nov 11, 2026
EPS Estimate (next Q) -$0.93
EPS Growth Est (next Q) -76.5%
Revenue Est (next Q) $8.43M
Revenue Growth Est (next Q) -90.9%
Fair Value Estimates
Graham Number $114.52
Graham Upside 254.8%
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $35.50
Price Target Upside 10.0%
Cash Flow
Operating Cash Flow €-192.82M
Free Cash Flow €-197.4M
Adj. Free Cash Flow €-197.4M
FCF Per Share -$4.57
OCF Per Share -$4.44
OCF/S Ratio -28.0%
Income Statement
Revenue €990.58M
Gross Profit €939.84M
Operating Income €609.93M
EBITDA €541.6M
Net Income €596.64M
EPS (Diluted) $9.05
Revenue / Employee $2.19M
Profit / Employee $1.32M
Employees 452
Add to Watchlist
Select watchlists to add or remove LKFT